Every October, the world comes together to observe Breast Cancer Awareness Month, a global campaign aimed at educating the public about breast cancer, emphasizing the importance of early detection, and supporting those affected by the disease. First launched in 1985 as a week-long awareness initiative, it has since grown into a month-long campaign that engages patients healthcare organizations, advocacy groups, and communities worldwide. This year’s theme, “No-one should face breast cancer alone“, emphasizes the importance of community and support for those impacted by breast cancer and reflects the ongoing efforts to reduce the stigma around the disease and encourage early detection, while also addressing disparities in access to care, particularly in resource-limited settings.

What is Breast Cancer and why early detection matters

Breast cancer is the most common cancer among women, accounting for 2.3 million new cases globally each year. It occurs when cells in the breast begin to grow uncontrollably, forming a lump or tumor. While breast cancer primarily affects women, men can also be diagnosed, though it is much rarer in males.

Early symptoms and warning signs of breast cancer may include:

– A new lump in the breast or underarm

– Changes in breast size or shape

– Dimpling or irritation of breast skin

– Unexplained pain in the breast or nipple

– Nipple discharge that isn’t breast milk

Early detection of breast cancer dramatically increases the chances of successful treatment which could lead to a cure. Regular screening, particularly through mammograms starting at age 40 (or earlier for those at higher risk), and breast ultrasound for those with dense breast tissue is a key tool in identifying cancer before it shows symptoms. Self-examinations and staying informed about the warning signs also empower individuals to take charge of their breast health. 

Breast Cancer Awareness Month: how can you get involved?

There are several ways to participate in Breast Cancer Awareness Month and make a positive impact:

– Get Screened: Schedule your annual mammogram and encourage friends and family to do the same especially those with strong family history. Early detection saves lives.

– Educate Yourself and Others: Learn about breast cancer, its risk factors, and how to recognize early signs. Share this information to raise awareness.

– Support People with Breast Cancer: If you know someone living with breast cancer, reach out to offer your support and ask how they’re doing. Sometimes, a simple check-in can mean a lot.

– Join Advocacy and Fundraising Efforts: Consider donating to breast cancer research organizations or participating in local or virtual events that raise funds for research and support programs.

By taking these actions, you can contribute to the ongoing fight against breast cancer and help spread the message that early detection and support are critical.

Menarini Group at the forefront in the fight against Breast Cancer

As a global leader in the field of oncology, Menarini Group, together with Stemline, a Menarini Group company, is dedicated to making a difference in the lives of those affected by breast cancer through innovation, precision medicine, and a patient-centered approach. The company recognizes that breast cancer is not just a medical condition—it’s a life-altering experience that requires a comprehensive approach to treatment and support.

True to its Oncology Manifesto, Menarini aims to continuously improve its understanding of breast cancer to deliver treatments that address the unique unmet needs of each patient. 

In the words of Juan de Galvagni, Vice President, Head of Global Commercial Oncology at Menarini Stemline, “In the time it takes you to read this, at least one more person will be diagnosed with breast cancer. I’m incredibly proud that at Menarini Stemline we have the commitment, energy and passion to help patients and caregivers impacted by one of the most frequent worldwide cancers with an unique drug that allows patients to choose hope. They are waiting, we should act!”

These words are also echoed by Tomer Wasserman, Vice President, Head of Global Medical Affairs, Solid Tumors: “In 2024 1.7 million people will receive a diagnosis of ER+, HER2- breast cancer. This number underscores the unmet needs in early and metastatic disease. We at Menarini, are dedicated to improving patients’ outcomes, by putting out endless effort to increase access to optimal diagnosis and care. Join us in supporting all clinical development, diagnosis, treatment and access initiatives so no patients are left behind.”

The company’s efforts are thus aligned with the World Health Organization’s Global Breast Cancer Initiative, which aims to reduce breast cancer mortality by 2.5% annually through early detection and improved access to care.

Menarini’s approach to breast cancer treatment reflects the Company’s mission to elevate standards of care, transforming the landscape of oncology and making a significant impact on every life touched by cancer.